Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 137 Pages
Report ld: 6486993
Request Sample
Customized Report
The global Valacyclovir Hydrochloride market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Valacyclovir Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
The North American market for Valacyclovir Hydrochloride is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Valacyclovir Hydrochloride is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Valacyclovir Hydrochloride include Ambeed, Atul Ltd, BioCrick BioTech, BioVision Inc, Glentham Life Sciences Limited, HuaHai, Molekula Group, MuseChem, Pharmaffiliates, Shanghai Pufei Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Valacyclovir Hydrochloride market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Valacyclovir Hydrochloride. The Valacyclovir Hydrochloride market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Valacyclovir Hydrochloride market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Valacyclovir Hydrochloride manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Valacyclovir Hydrochloride manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Valacyclovir Hydrochloride production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Valacyclovir Hydrochloride consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Valacyclovir Hydrochloride Market Overview
1.1 Product Definition
1.2 Valacyclovir Hydrochloride by Type
1.2.1 Global Valacyclovir Hydrochloride Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.3 Valacyclovir Hydrochloride by Application
1.3.1 Global Valacyclovir Hydrochloride Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Medicine
1.3.3 Chemical
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Valacyclovir Hydrochloride Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Valacyclovir Hydrochloride Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Valacyclovir Hydrochloride Production Estimates and Forecasts (2021–2032)
1.4.4 Global Valacyclovir Hydrochloride Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Valacyclovir Hydrochloride Production Market Share by Manufacturers (2021–2026)
2.2 Global Valacyclovir Hydrochloride Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Valacyclovir Hydrochloride, Industry Ranking, 2024 vs 2025
2.4 Global Valacyclovir Hydrochloride Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Valacyclovir Hydrochloride Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Valacyclovir Hydrochloride, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Valacyclovir Hydrochloride, Product Offerings and Applications
2.8 Global Key Manufacturers of Valacyclovir Hydrochloride, Date of Entry into the Industry
2.9 Valacyclovir Hydrochloride Market Competitive Situation and Trends
2.9.1 Valacyclovir Hydrochloride Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Valacyclovir Hydrochloride Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Valacyclovir Hydrochloride Production by Region
3.1 Global Valacyclovir Hydrochloride Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Valacyclovir Hydrochloride Production Value by Region (2021–2032)
3.2.1 Global Valacyclovir Hydrochloride Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Valacyclovir Hydrochloride by Region (2027–2032)
3.3 Global Valacyclovir Hydrochloride Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Valacyclovir Hydrochloride Production Volume by Region (2021–2032)
3.4.1 Global Valacyclovir Hydrochloride Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Valacyclovir Hydrochloride by Region (2027–2032)
3.5 Global Valacyclovir Hydrochloride Market Price Analysis by Region (2021–2032)
3.6 Global Valacyclovir Hydrochloride Production, Value, and Year-over-Year Growth
3.6.1 North America Valacyclovir Hydrochloride Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Valacyclovir Hydrochloride Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Valacyclovir Hydrochloride Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Valacyclovir Hydrochloride Production Value Estimates and Forecasts (2021–2032)
4 Valacyclovir Hydrochloride Consumption by Region
4.1 Global Valacyclovir Hydrochloride Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Valacyclovir Hydrochloride Consumption by Region (2021–2032)
4.2.1 Global Valacyclovir Hydrochloride Consumption by Region (2021–2026)
4.2.2 Global Valacyclovir Hydrochloride Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Valacyclovir Hydrochloride Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Valacyclovir Hydrochloride Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Valacyclovir Hydrochloride Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Valacyclovir Hydrochloride Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Valacyclovir Hydrochloride Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Valacyclovir Hydrochloride Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Valacyclovir Hydrochloride Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Valacyclovir Hydrochloride Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Valacyclovir Hydrochloride Production by Type (2021–2032)
5.1.1 Global Valacyclovir Hydrochloride Production by Type (2021–2026)
5.1.2 Global Valacyclovir Hydrochloride Production by Type (2027–2032)
5.1.3 Global Valacyclovir Hydrochloride Production Market Share by Type (2021–2032)
5.2 Global Valacyclovir Hydrochloride Production Value by Type (2021–2032)
5.2.1 Global Valacyclovir Hydrochloride Production Value by Type (2021–2026)
5.2.2 Global Valacyclovir Hydrochloride Production Value by Type (2027–2032)
5.2.3 Global Valacyclovir Hydrochloride Production Value Market Share by Type (2021–2032)
5.3 Global Valacyclovir Hydrochloride Price by Type (2021–2032)
6 Segment by Application
6.1 Global Valacyclovir Hydrochloride Production by Application (2021–2032)
6.1.1 Global Valacyclovir Hydrochloride Production by Application (2021–2026)
6.1.2 Global Valacyclovir Hydrochloride Production by Application (2027–2032)
6.1.3 Global Valacyclovir Hydrochloride Production Market Share by Application (2021–2032)
6.2 Global Valacyclovir Hydrochloride Production Value by Application (2021–2032)
6.2.1 Global Valacyclovir Hydrochloride Production Value by Application (2021–2026)
6.2.2 Global Valacyclovir Hydrochloride Production Value by Application (2027–2032)
6.2.3 Global Valacyclovir Hydrochloride Production Value Market Share by Application (2021–2032)
6.3 Global Valacyclovir Hydrochloride Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Ambeed
7.1.1 Ambeed Valacyclovir Hydrochloride Company Information
7.1.2 Ambeed Valacyclovir Hydrochloride Product Portfolio
7.1.3 Ambeed Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Ambeed Main Business and Markets Served
7.1.5 Ambeed Recent Developments/Updates
7.2 Atul Ltd
7.2.1 Atul Ltd Valacyclovir Hydrochloride Company Information
7.2.2 Atul Ltd Valacyclovir Hydrochloride Product Portfolio
7.2.3 Atul Ltd Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Atul Ltd Main Business and Markets Served
7.2.5 Atul Ltd Recent Developments/Updates
7.3 BioCrick BioTech
7.3.1 BioCrick BioTech Valacyclovir Hydrochloride Company Information
7.3.2 BioCrick BioTech Valacyclovir Hydrochloride Product Portfolio
7.3.3 BioCrick BioTech Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 BioCrick BioTech Main Business and Markets Served
7.3.5 BioCrick BioTech Recent Developments/Updates
7.4 BioVision Inc
7.4.1 BioVision Inc Valacyclovir Hydrochloride Company Information
7.4.2 BioVision Inc Valacyclovir Hydrochloride Product Portfolio
7.4.3 BioVision Inc Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 BioVision Inc Main Business and Markets Served
7.4.5 BioVision Inc Recent Developments/Updates
7.5 Glentham Life Sciences Limited
7.5.1 Glentham Life Sciences Limited Valacyclovir Hydrochloride Company Information
7.5.2 Glentham Life Sciences Limited Valacyclovir Hydrochloride Product Portfolio
7.5.3 Glentham Life Sciences Limited Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Glentham Life Sciences Limited Main Business and Markets Served
7.5.5 Glentham Life Sciences Limited Recent Developments/Updates
7.6 HuaHai
7.6.1 HuaHai Valacyclovir Hydrochloride Company Information
7.6.2 HuaHai Valacyclovir Hydrochloride Product Portfolio
7.6.3 HuaHai Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 HuaHai Main Business and Markets Served
7.6.5 HuaHai Recent Developments/Updates
7.7 Molekula Group
7.7.1 Molekula Group Valacyclovir Hydrochloride Company Information
7.7.2 Molekula Group Valacyclovir Hydrochloride Product Portfolio
7.7.3 Molekula Group Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Molekula Group Main Business and Markets Served
7.7.5 Molekula Group Recent Developments/Updates
7.8 MuseChem
7.8.1 MuseChem Valacyclovir Hydrochloride Company Information
7.8.2 MuseChem Valacyclovir Hydrochloride Product Portfolio
7.8.3 MuseChem Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 MuseChem Main Business and Markets Served
7.8.5 MuseChem Recent Developments/Updates
7.9 Pharmaffiliates
7.9.1 Pharmaffiliates Valacyclovir Hydrochloride Company Information
7.9.2 Pharmaffiliates Valacyclovir Hydrochloride Product Portfolio
7.9.3 Pharmaffiliates Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Pharmaffiliates Main Business and Markets Served
7.9.5 Pharmaffiliates Recent Developments/Updates
7.10 Shanghai Pufei Biotechnology
7.10.1 Shanghai Pufei Biotechnology Valacyclovir Hydrochloride Company Information
7.10.2 Shanghai Pufei Biotechnology Valacyclovir Hydrochloride Product Portfolio
7.10.3 Shanghai Pufei Biotechnology Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Shanghai Pufei Biotechnology Main Business and Markets Served
7.10.5 Shanghai Pufei Biotechnology Recent Developments/Updates
7.11 Spectrum Chemical
7.11.1 Spectrum Chemical Valacyclovir Hydrochloride Company Information
7.11.2 Spectrum Chemical Valacyclovir Hydrochloride Product Portfolio
7.11.3 Spectrum Chemical Valacyclovir Hydrochloride Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Spectrum Chemical Main Business and Markets Served
7.11.5 Spectrum Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Valacyclovir Hydrochloride Industry Chain Analysis
8.2 Valacyclovir Hydrochloride Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Valacyclovir Hydrochloride Production Modes and Processes
8.4 Valacyclovir Hydrochloride Sales and Marketing
8.4.1 Valacyclovir Hydrochloride Sales Channels
8.4.2 Valacyclovir Hydrochloride Distributors
8.5 Valacyclovir Hydrochloride Customer Analysis
9 Valacyclovir Hydrochloride Market Dynamics
9.1 Valacyclovir Hydrochloride Industry Trends
9.2 Valacyclovir Hydrochloride Market Drivers
9.3 Valacyclovir Hydrochloride Market Challenges
9.4 Valacyclovir Hydrochloride Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
The global Valacyclovir Hydrochloride market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 93
USD 4250.00
(Single User License)
The global Valacyclovir Hydrochloride market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 155
USD 4900.00
(Single User License)
The global market for Valacyclovir Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-09
Pages: 100
USD 2900.00
(Single User License)
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 120
USD 3950.00
(Single User License)
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-04-12
Pages: 109
USD 4900.00
(Single User License)
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-01-17
Pages: 99
USD 2900.00
(Single User License)
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-01-07
Pages: 123
USD 3950.00
(Single User License)
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 139
The global Valacyclovir Hydrochloride market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 93
The global Valacyclovir Hydrochloride market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 155
The global market for Valacyclovir Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-09
Pages: 100
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 120
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-04-12
Pages: 109
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-01-17
Pages: 99
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-01-07
Pages: 123
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now